Connor Wurst, Huei-Yen Winnie Chen, Robert Wahler, Kelly Tenzek, Ranjit Singh, Matthew Cosmai, Alexandria Wahler, Scott Monte
{"title":"Control Task Analysis of the Deprescription Process: A Pilot Study","authors":"Connor Wurst, Huei-Yen Winnie Chen, Robert Wahler, Kelly Tenzek, Ranjit Singh, Matthew Cosmai, Alexandria Wahler, Scott Monte","doi":"10.1177/21695067231200874","DOIUrl":null,"url":null,"abstract":"Deprescription is the process by which a physician supervises a patient’s withdrawal or dose reduction of a given medication due to side effects or diminishing efficacy. Prior studies on the process of deprescription have resulted in a number of models, two of which are used in this pilot study alongside the decision ladder to construct a novel analytic method. Initial findings indicate that this approach can offer unique insight into the deprescription process, particularly regarding the paths physicians take through the decision making process and when certain factors are most important. These early results are limited but lay the foundation for a rich variety of future work.","PeriodicalId":74544,"journal":{"name":"Proceedings of the Human Factors and Ergonomics Society ... Annual Meeting. Human Factors and Ergonomics Society. Annual meeting","volume":"6 11","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the Human Factors and Ergonomics Society ... Annual Meeting. Human Factors and Ergonomics Society. Annual meeting","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/21695067231200874","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Deprescription is the process by which a physician supervises a patient’s withdrawal or dose reduction of a given medication due to side effects or diminishing efficacy. Prior studies on the process of deprescription have resulted in a number of models, two of which are used in this pilot study alongside the decision ladder to construct a novel analytic method. Initial findings indicate that this approach can offer unique insight into the deprescription process, particularly regarding the paths physicians take through the decision making process and when certain factors are most important. These early results are limited but lay the foundation for a rich variety of future work.